Survey Question | Cardiologists | Oncologists | P-value | ||
---|---|---|---|---|---|
Yes (n (%)) | No (n (%)) | Yes (n (%)) | No (n (%)) | Statistical significance < 0.05 | |
“Does your institution provide proper protection for all health care workers to the level they are exposed?” | 684 (70.6%) | 285 (29.4%) | 210 (69.3%) | 93 (30.7%) | P = 0.598 |
“Have timely surgery/chemo/immunotherapy treatments for your patients been delayed since the COVID-19 pandemic started?” | 498 (56.4%) | 385 (43.6%) | 152 (50%) | 152 (50%) | P < 0.001 |
“Do you use telemedicine to reduce in-person encounters and health care providers’ exposure?” | 818 (85.0%) | 151 (15.0%) | 269 (89.4%) | 32 (10.6%) | P = 0.085 |
“Have you been asked to reduce your specialized practice to help/contribute to other areas where urgent help is needed?” | 442 (45.5%) | 529 (54.5%) | 76 (25.2%) | 226 (74.8%) | P < 0.001 |
“Have you had in service instruction/guidelines from leadership at your institution about policies to protect your patients, your team, your colleagues and yourself?” | 839 (86.1%) | 136 (13.9%) | 272 (89.2%) | 33 (10.8%) | P = 0.168 |
“Do you feel you have adequate support from your institution’s leadership to carry on with your duties?” | 690 (71.5%) | 275 (28.5%) | 232 (76.1%) | 73 (23.9%) | P = 0.030 |
“Do you discuss with all your patients the importance of strict adherence to COVID-19 community behavior as part of your office/clinic encounters?” | 885 (91.5%) | 82 (8.5%) | 285 (95%) | 15 (5%) | P = 0.141 |
“Do you have access to COVID-19 testing at your institution or local lab?” | 730 (75.1%) | 242 (24.9%) | 205 (67.4%) | 99 (32.6%) | P = 0.017 |
“Has your institution used Tocilizumab or other anti-inflammatory agents for COVID-19 related myocarditis?” | 130 (15.1%) | 733 (84.9%) | 42 (16.7%) | 210 (83.3%) | P = 0.059 |
Has your institution used empiric treatment with Remdesivir or other anti-viral treatments for the sickest patients? | 289 (32.7%) | 595 (67.3%) | 69 (26.1%) | 195 (73.9%) | P = 0.035 |
“In your opinion, should there be a government mandated nationwide quarantine/lock-down to slow down the propagation/transmission of COVID-19?” | 826 (85.7%) | 138 (14.3%) | 259 (86.6%) | 40 (13.4%) | P = 0.909 |
“Should medical professional organizations take a more active role, and have more influence in official health care policy decisions during this major crisis?” | 926 (95.2%) | 47 (4.8% | 289 (95.7%) | 13 (4.3%) | P = 0.931 |